Is a complete TVRD research report available?

No complete published report is available for Tvardi Therapeutics, Inc. (TVRD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Tvardi Therapeutics, Inc. (TVRD)

NASDAQ: TVRD · USD

$0.91

+0.04 (+4.9%)· Recorded snapshot

Market cap	12.1M
Net income (ttm)	-26.1M
EPS (ttm)	-$2.77
Shares out	13.3M
Volume	85,833

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -26.1M
EPS (ttm): -$2.77
Market cap: 12.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Держать

Metric	Value
Amount currency	USD
CIK code	0001346830
Company name	Tvardi Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	140755307
Earnings date	2026-11-12
Earnings time	bmo
Employees	12
Enterprise value	$-3.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US1407553072
Last 10-K release date	2026-03-31
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$12.1M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$0.91
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	TVRD
U.S. state	Texas
Website	https://tvarditherapeutics.com

Metric

Value

Amount currency

USD

CIK code

0001346830

Company name

Tvardi Therapeutics, Inc.

Country

United States

Country code

CUSIP number

140755307

Earnings date

2026-11-12

Earnings time

bmo

Employees

Enterprise value

$-3.5M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2017

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US1407553072

Last 10-K release date

2026-03-31

Last earnings date

2026-08-14

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$12.1M

Market cap category

Nano-Cap

Next earnings date

2026-11-12

Options

Yes

Price

$0.91

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

TVRD

U.S. state

Texas

Website

https://tvarditherapeutics.com

Metric	Value
Earnings yield	-305.48%
FCF / EV yield	613.78%
FCF yield	-216.85%
P/B ratio	0.97x
Price / tangible book value	1.43x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-305.48%

FCF / EV yield

613.78%

FCF yield

-216.85%

P/B ratio

0.97x

Price / tangible book value

1.43x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-2.2M
ROA	-55.51%
ROCE	-323.71%
ROE	-126.19%
ROIC	-81.53%

Metric

Value

Profit per employee

$-2.2M

ROA

-55.51%

ROCE

-323.71%

ROE

-126.19%

ROIC

-81.53%

Metric	Value
EPS growth quarters	9
EPS growth years	2
Net income growth years	2
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Depreciation and amortization	$95,000
EBIT	$-27.2M
EBITDA	$-27.1M
EPS	$-2.77
FCF per share	$-1.88
Financing cash flow	$-321,000
Free cash flow	$-25M
Free cash flow minus SBC	$-26.4M
Investing cash flow	$20.5M
Net cash flow	$-4.9M
Net income	$-26.1M
Operating cash flow minus SBC	$-26.4M
Operating income	$-27.2M
Stock-based compensation	$1.4M

Metric

Value

Depreciation and amortization

$95,000

EBIT

$-27.2M

EBITDA

$-27.1M

EPS

$-2.77

FCF per share

$-1.88

Financing cash flow

$-321,000

Free cash flow

$-25M

Free cash flow minus SBC

$-26.4M

Investing cash flow

$20.5M

Net cash flow

$-4.9M

Net income

$-26.1M

Operating cash flow minus SBC

$-26.4M

Operating income

$-27.2M

Stock-based compensation

$1.4M

Metric	Value
Book value per share	$0.89
Debt / equity	0.02
Long-term assets	$448,000
Long-term liabilities	$22,000
Net cash (debt)	$15.6M
Net cash / market cap	135.33%
Net cash growth	-61.66%
Net debt / equity	-1.86
Piotroski F-Score	1
Property, plant and equipment	$140,000
Shareholders' equity	$8.4M
Tangible book value	$8.1M
Tangible book value per share	$0.86
Total assets	$17.5M
Total cash	$15.8M
Total debt	$145,000
Total liabilities	$9.1M

Metric

Value

Book value per share

$0.89

Debt / equity

0.02

Long-term assets

$448,000

Long-term liabilities

$22,000

Net cash (debt)

$15.6M

Net cash / market cap

135.33%

Net cash growth

-61.66%

Net debt / equity

-1.86

Piotroski F-Score

Property, plant and equipment

$140,000

Shareholders' equity

$8.4M

Tangible book value

$8.1M

Tangible book value per share

$0.86

Total assets

$17.5M

Total cash

$15.8M

Total debt

$145,000

Total liabilities

$9.1M

Metric	Value
Current assets	$17.1M
Current liabilities	$9.1M
Current ratio	1.87
Net working capital	$-7.7M
Quick ratio	1.73
Working capital	$8M

Metric

Value

Current assets

$17.1M

Current liabilities

$9.1M

Current ratio

1.87

Net working capital

$-7.7M

Quick ratio

1.73

Working capital

$8M

Metric	Value
Buyback yield / dilution	-134.87%
Dividend yield	0%
Shareholder yield	-134.87%

Metric

Value

Buyback yield / dilution

-134.87%

Dividend yield

Shareholder yield

-134.87%

Metric	Value
150-day SMA	$2.42
1D price change	4.93%
1M price change	-27.33%
1M total return	-27.33%
1W price change	-6.97%
1W total return	-6.97%
1Y price change	-81.05%
1Y return CAGR	-81.07%
1Y total return	-81.05%
20-day SMA	$1.03
200-day SMA	$2.80
3M price change	-63.67%
3M total return	-63.67%
50-day SMA	$1.42
50-day SMA vs 200-day SMA	50under200
52-week high	$5.69
52-week high date	2026-07-08
52-week low	$0.83
52-week low date	2026-10-27
6M price change	-69.64%
6M total return	-69.64%
All-time high	$43.65
All-time high date	2025-10-10
All-time low	$0.83
All-time low date	2026-10-27
Average true range (ATR)	$0.11
Average volume	146.3K
Beta (1Y)	2.64
Beta (2Y)	1.5
Change from 52-week high	-84.04%
Change from 52-week low	9.27%
Change from all-time high	-97.89%
Change from all-time low	11.06%
Change from open	-0.22%
Day's gap	5.17%
Dollar volume	$77,936
High price	$0.91
Low price	$0.91
Monthly RSI	30.13
Open price	$0.91
Position in 52-week range	0%
Premarket change	4.01%
Premarket close	$0.87
Premarket price	$0.90
Premarket volume	335
Previous close	$0.87
Price vs 150-day SMA	-61.82%
Price vs 20-day SMA	-10.05%
Price vs 200-day SMA	-67%
Price vs 50-day SMA	-35.05%
Relative volume	0.59
RSI	34.54
Sharpe ratio	-0.87
Sortino ratio	-1.42
Volume	85.8K
Weekly RSI	30.86
YTD price change	-78.54%
YTD total return	-78.54%

Metric

Value

150-day SMA

$2.42

1D price change

4.93%

1M price change

-27.33%

1M total return

-27.33%

1W price change

-6.97%

1W total return

-6.97%

1Y price change

-81.05%

1Y return CAGR

-81.07%

1Y total return

-81.05%

20-day SMA

$1.03

200-day SMA

$2.80

3M price change

-63.67%

3M total return

-63.67%

50-day SMA

$1.42

50-day SMA vs 200-day SMA

50under200

52-week high

$5.69

52-week high date

2026-07-08

52-week low

$0.83

52-week low date

2026-10-27

6M price change

-69.64%

6M total return

-69.64%

All-time high

$43.65

All-time high date

2025-10-10

All-time low

$0.83

All-time low date

2026-10-27

Average true range (ATR)

$0.11

Average volume

146.3K

Beta (1Y)

2.64

Beta (2Y)

1.5

Change from 52-week high

-84.04%

Change from 52-week low

9.27%

Change from all-time high

-97.89%

Change from all-time low

11.06%

Change from open

-0.22%

Day's gap

5.17%

Dollar volume

$77,936

High price

$0.91

Low price

$0.91

Monthly RSI

30.13

Open price

$0.91

Position in 52-week range

Premarket change

4.01%

Premarket close

$0.87

Premarket price

$0.90

Premarket volume

335

Previous close

$0.87

Price vs 150-day SMA

-61.82%

Price vs 20-day SMA

-10.05%

Price vs 200-day SMA

-67%

Price vs 50-day SMA

-35.05%

Relative volume

0.59

RSI

34.54

Sharpe ratio

-0.87

Sortino ratio

-1.42

Volume

85.8K

Weekly RSI

30.86

YTD price change

-78.54%

YTD total return

-78.54%

Metric	Value
Float	9.6M
Float percentage	72.19%
Shares change (QoQ)	0%
Shares change (YoY)	134.87%
Shares held by insiders	16.31%
Shares held by institutions	18.99%
Shares outstanding	13.3M
Short % of float	2.33%
Short % of shares	1.68%
Short ratio	1.1 days

Metric

Value

Float

9.6M

Float percentage

72.19%

Shares change (QoQ)

Shares change (YoY)

134.87%

Shares held by insiders

16.31%

Shares held by institutions

18.99%

Shares outstanding

13.3M

Short % of float

2.33%

Short % of shares

1.68%

Short ratio

1.1 days

Tvardi Therapeutics, Inc. (TVRD)

Price

Financial snapshot

Fair-value bridge

Latest news · TVRD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TVRD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TVRD

Frequently asked questions